Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: LOVELACE BIOMEDICAL RESEARCH INSTITUTE
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2021-09-24 to 2024-10-31
Current total value of award: $1283044
Description: CHARACTERIZATION OF A NON-PARALYZING BONT-BASED BIOPHARMACEUTICAL FOR THE TREATMENT OF NEUROPATHIC PAIN